Alumis Inc. Scheduled to Announce Q3 2026 Financial Results
Alumis Inc. has scheduled the release of its financial results for the third quarter of 2026 for November 12, 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Alumis Inc. has scheduled the release of its financial results for the third quarter of 2026 for November 12, 2026.
– Results build on ONWARD3 highest complete skin clearance (54% PASI 100) at Week 48, reinforcing envudeucitinib’s potential to become a leading oral therapy for moderate-to-severe plaque psoriasis– Patients switching
U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other stocks rallied on strong results.
Analysts upgraded Alumis, Sirius XM, OGE Energy, revising their price targets and outlooks.